APOL1 and diabetes mellitus: The analysis of the CRIC cohort extended these results to patients affected with diabetes, using a Caucasian cohort as the comparison group: among the patients with diabetes the decline in eGFR was−1.5 mL/min/1.73m2 per year in Caucasian patients, versu -2.7 in African ancestry patients in the APOL1 low-risk group, and−4.3 in African ancestry patients in the ApoL1 high risk group, while it was analogous in non-diabetic patients, (respectively: −0.7, −1.0, −2.9).